Announced Sat, 25 Jul · 14:39 IST
Glenmark publishes notice for transfer of shares to IEPF Authority
Compliance View source PDF
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹2201.00
prior close
₹2218.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.3-0.1-0.5——————————
Up moveDown movePending
AI summary
Glenmark Pharmaceuticals published newspaper notices in Financial Express (English) and Loksatta (Marathi) on July 25, 2026, informing shareholders about the upcoming transfer of equity shares to the Investor Education and Protection Fund (IEPF) Authority. This is a routine compliance filing under Section 124(6) of the Companies Act, 2013, typically covering shares where dividends have remained unclaimed for seven or more years. The notice is also available on the company website.
Likely market impact
Routine compliance filing. Shareholders with unclaimed dividends should claim shares before transfer to IEPF happens.